![William Earnest Pullman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
William Earnest Pullman
Direttore/Membro del Consiglio presso USL Pharma International UK Ltd.
Posizioni attive di William Earnest Pullman
Società | Posizione | Inizio | Fine |
---|---|---|---|
USL Pharma International UK Ltd.
![]() USL Pharma International UK Ltd. Pharmaceuticals: MajorHealth Technology USL Pharma International UK Ltd. operates as a holding company whose subsidiaries engages in the development of drugs for the treatment of neurological and inflammatory disorders. The company was founded on June 8, 2012 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | 18/12/2013 | - |
Proximagen Group Plc
![]() Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom. | Direttore/Membro del Consiglio | 18/12/2013 | - |
Storia della carriera di William Earnest Pullman
Precedenti posizioni note di William Earnest Pullman
Società | Posizione | Inizio | Fine |
---|---|---|---|
DYAX CORP. | Direttore Tecnico/Scientifico/R&S | 09/06/2011 | - |
Corporate Officer/Principal | 01/10/2007 | 09/06/2011 | |
TransForm Pharmaceuticals, Inc.
![]() TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA. | Corporate Officer/Principal | - | - |
CUBIST PHARMACEUTICALS INC | Direttore Tecnico/Scientifico/R&S | 01/05/2006 | - |
Formazione di William Earnest Pullman
Australian National University | Doctorate Degree |
The University of Western Australia | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Regno Unito | 3 |
Australia | 3 |
Posizioni
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 2 |
Settori
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 5 |
---|---|
Cubist Pharmaceuticals LLC
![]() Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Dyax Corp.
![]() Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
Proximagen Group Plc
![]() Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
TransForm Pharmaceuticals, Inc.
![]() TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA. | Health Technology |
USL Pharma International UK Ltd.
![]() USL Pharma International UK Ltd. Pharmaceuticals: MajorHealth Technology USL Pharma International UK Ltd. operates as a holding company whose subsidiaries engages in the development of drugs for the treatment of neurological and inflammatory disorders. The company was founded on June 8, 2012 and is headquartered in London, the United Kingdom. | Health Technology |